Politische Schubladen als theoretische Heuristik. Methodische Aspekte politischer Bedeutungsverschiebungen in Naturbildern

Der vorliegende Band versammelt die umgearbeiteten Beiträge einer Tagung, die im März 2002 im Warburg-Haus in Hamburg stattfand. Sie wurde im Rahmen des Forschungsprojekts „Natur im Konflikt“ veranstaltet, das von der Volkswagenstiftung innerhalb des Förderprogramms „Schlüsselthemen der Geisteswissenschaften“ finanziert wird. Dieses interdisziplinäre Vorhaben widmet sich der Untersuchung von mentalen Konzepten, Bildern, Modellen und Wertzuschreibungen, die zum kollektiven Fundus unserer Vorstellungen von Natur gehören. Dabei richten sich die Untersuchungen aus der Perspektive verschiedener Fachrichtungen – Ethnologie bzw. Sozialanthropologie, Geschichtswissenschaft, naturwissenschaftliche Küstenforschung, Literatur-, Sprach- und Medienwissenschaft – insbesondere auf die diejenigen Naturbilder und Modellierungen, die zu den oft nicht thematisierten Argumentationen und Überzeugungen gehören.This volume collects the revised contributions of a conference that took place in March 2002 at the Warburg-Haus in Hamburg. It was organised as part of the "Nature in Conflict" research project, which was funded by the Volkswagen Foundation within the framework of the "Key Humanities Issues" funding programme. This interdisciplinary project was dedicated to the investigation of mental concepts, images, models and value attributions that belong to the collective fund of our ideas of nature. In this context, the investigations are directed from the perspective of various disciplines - ethnology or social anthropology, history, coastal research in the natural sciences, literature, linguistics and media studies - in particular at those images of nature and models that belong to the argumentations and convictions that are often not discussed

Microglia-Astrocyte Communication in Alzheimer's Disease

Microglia and astrocytes are regarded as active participants in the central nervous system under various neuropathological conditions, including Alzheimer's disease (AD). Both microglia and astrocyte activation have been reported to occur with a spatially and temporarily distinct pattern. Acting as a double-edged sword, glia-mediated neuroinflammation may be both detrimental and beneficial to the brain. In a variety of neuropathologies, microglia are activated before astrocytes, which facilitates astrocyte activation. Yet reactive astrocytes can also prevent the activation of adjacent microglia in addition to helping them become activated. Studies describe changes in the genetic profile as well as cellular and molecular responses of these two types of glial cells that contribute to dysfunctional immune crosstalk in AD. In this paper, we construct current knowledge of microglia-astrocyte communication, highlighting the multifaceted functions of microglia and astrocytes and their role in AD. A thorough comprehension of microglia-astrocyte communication could hasten the creation of novel AD treatment approaches.</p

The cytotoxin of Pseudomonas aeruginosa:Cytotoxicity requires proteolytic activation

The primary structure of a cytotoxin from Pseudomonas aeruginosa was determined by sequencing of the structural gene. The cytotoxin (31,700 Mr) lacks an N-terminal signal sequence for bacterial secretion but contains a pentapeptide consensus sequence commonly found in prokaryotic proteins which function in a TonB-dependent manner. The cytotoxin gene has a [G + C]-content of 53.8% which is considerably lower than generally observed for genes from Pseudomonas aeruginosa. The cytotoxin gene was exclusively detected in strain 158 but not in three other clinical isolates, as determined by Southern and Northern hybridization. The latter technique revealed that the toxin is translated from monocistronic mRNA. The promoter of the cytotoxin is inactive in Escherichia coli. Upon site-directed modification of the 5'-noncoding region by the polymerase chain reaction the gene was expressed under control of the trc-promoter. The gene product obtained in Escherichia coli was nontoxic. Toxicity was induced by subsequent treatment with trypsin. [35S]methionine-labeled cytotoxin with high specific radioactivity was obtained by in vitro transcription/translation. Like [125I] labeled material from Pseudomonas aeruginosa this polypeptide bound to membrane preparations from Ehrlich ascites cells, as evidenced by sedimentation through a sucrose gradient at neutral pH

Aging of the brain

An increasing number of persons live for nine or more decades and enjoy the benefits of a well-functioning brain until the end of their life. In that respect, the cognitive performance in later life and the quality maintenance of the brain are amazing biological phenomena. Since most nerve cells are generated during pregnancy and have to survive an active lifetime, the brain has to be endowed with a maintenance machinery of surprising long-term quality. During successful, that is, non-pathological, aging in most brain regions, there is very little or no evidence for a decrease in numbers of neurons. In some brain structures, a limited reduction of nerve cells may occur, but it is generally conceived that aging and aging-related cognitive impairments are not the result of massive cell loss but rather the result of synaptic changes, receptor dysfunction or signaling deficits, and metabolic decline. Besides, nerve cell loss during normal aging may be compensated by synaptogenesis, dendritic branching, or in certain brain structures like dentate gyrus by neurogenesis from progenitor stem cells. Yet most human individuals suffer from a mild but life-disturbing condition we call agingrelated memory impairment (AMI). In this chapter, some of the mechanisms will be shortly explored that are considered to be causal to non-pathological deterioration of cognitive faculties. In particular several cellular and molecular neuronal changes will be addressed that occur during aging, the consequences for interneuronal communication and membrane potential, the blood supply to the brain and cerebrovascular condition, and some observations on the protective neuroimmune system of the brain

Novel diagnostic method for diagnosing depression and monitoring therapy effectiveness

The present invention relates to a method of diagnosing or monitoring the progression of a mood disorder, by assaying the level of lipocalin-2 in the body fluid of a subject. Preferably said mood disorder is depression, chosen from dysthymia, endogenous depression, minor depression, major depression, psychotic depression, neurotic depression, postnatal depression, burn out, overstrain, unipolar depression and bipolar depression. Also a combined detection of lipocalin-2 and BDNF for the method according to the invention is proposed

Novel diagnostic method for diagnosing depression and monitoring therapy effectiveness

The present invention relates to a method of diagnosing or monitoring the progression of a mood disorder, by assaying the level of lipocalin-2 in the body fluid of a subject. Preferably said mood disorder is depression, chosen from dysthymia, endogenous depression, minor depression, major depression, psychotic depression, neurotic depression, postnatal depression, burn out, overstrain, unipolar depression and bipolar depression. Also a combined detection of lipocalin-2 and BDNF for the method according to the invention is proposed

Novel diagnostic method for diagnosing depression and monitoring therapy effectiveness

The present invention relates to a method of diagnosing or monitoring the progression of a mood disorder, by assaying the level of lipocalin-2 in the body fluid of a subject. Preferably said mood disorder is depression, chosen from dysthymia, endogenous depression, minor depression, major depression, psychotic depression, neurotic depression, postnatal depression, burn out, overstrain, unipolar depression and bipolar depression. Also a combined detection of lipocalin-2 and BDNF for the method according to the invention is proposed